Compass Pathways announced that its investigational psilocybin treatment has successfully met its primary endpoint in a Phase ...
All rights reserved. Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement ...
Lawmakers urge DOJ to detail its review of the $1.6B Compass-Anywhere merger, citing risks to competition and housing costs.
*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title, registration ...
Compass will now seek approval for COMP360, which could become the first classic psychedelic to gain the FDA’s blessing.